166 related articles for article (PubMed ID: 2526110)
1. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV
J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Legionella species to antimicrobial agents.
Chen SC; Paul ML; Gilbert GL
Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
[TBL] [Abstract][Full Text] [Related]
3. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
[TBL] [Abstract][Full Text] [Related]
4. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
Onody C; Matsiota-Bernard P; Nauciel C
J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
[TBL] [Abstract][Full Text] [Related]
5. The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution method.
Jones RN; Barry AL
J Antimicrob Chemother; 1987 Jun; 19(6):841-2. PubMed ID: 2956231
[No Abstract] [Full Text] [Related]
6. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
7. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
8. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
10. Application of the Etest to antimicrobial susceptibility testing of Legionella spp.
Rhomberg PR; Bale MJ; Jones RN
Diagn Microbiol Infect Dis; 1994 Jul; 19(3):175-8. PubMed ID: 7820999
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Ruckdeschel G; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
[TBL] [Abstract][Full Text] [Related]
12. Evaluations of the Etest for antimicrobial susceptibility testing of Legionella pneumophila, including validation of the imipenem and sparfloxacin strips.
Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 1994 Nov; 20(3):159-62. PubMed ID: 7874883
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms.
Edelstein PH; Pasiecznik KA; Yasui VK; Meyer RD
Antimicrob Agents Chemother; 1982 Jul; 22(1):90-3. PubMed ID: 7125633
[TBL] [Abstract][Full Text] [Related]
14. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
Reznicek M; Bale M; Pfaller M
Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.
Martin SJ; Pendland SL; Chen C; Schreckenberger P; Danziger LH
Antimicrob Agents Chemother; 1996 Jun; 40(6):1419-21. PubMed ID: 8726012
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing by E-test and agar dilution of 30 strains of Legionella spp. isolated in Portugal.
Marques T; Piedade J
Clin Microbiol Infect; 1997 Jun; 3(3):365-368. PubMed ID: 11864134
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
Nielsen K; Bangsborg JM; Høiby N
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):43-8. PubMed ID: 10744366
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibiotic susceptibility of Legionellaceae: search for alternative antimicrobial drugs.
Traub WH; Spohr M
Chemotherapy; 1984; 30(3):182-7. PubMed ID: 6734305
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
